214 related articles for article (PubMed ID: 24205828)
1. Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.
Walline CC; Deffit SN; Wang N; Guindon LM; Crotzer VL; Liu J; Hollister K; Eisenlohr LC; Brutkiewicz RR; Kaplan MH; Blum JS
Immunology; 2014 Apr; 141(4):531-9. PubMed ID: 24205828
[TBL] [Abstract][Full Text] [Related]
2. Disruption of MHC class II-restricted antigen presentation by vaccinia virus.
Li P; Wang N; Zhou D; Yee CS; Chang CH; Brutkiewicz RR; Blum JS
J Immunol; 2005 Nov; 175(10):6481-8. PubMed ID: 16272302
[TBL] [Abstract][Full Text] [Related]
3. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.
Sette A; Moutaftsi M; Moyron-Quiroz J; McCausland MM; Davies DH; Johnston RJ; Peters B; Rafii-El-Idrissi Benhnia M; Hoffmann J; Su HP; Singh K; Garboczi DN; Head S; Grey H; Felgner PL; Crotty S
Immunity; 2008 Jun; 28(6):847-58. PubMed ID: 18549802
[TBL] [Abstract][Full Text] [Related]
4. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
[TBL] [Abstract][Full Text] [Related]
5. Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection.
Rudraraju R; Ramsay AJ
Vaccine; 2010 Jul; 28(31):4997-5004. PubMed ID: 20653083
[TBL] [Abstract][Full Text] [Related]
6. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
7. Diminished intracellular invariant chain expression after vaccinia virus infection.
Wang N; Weber E; Blum JS
J Immunol; 2009 Aug; 183(3):1542-50. PubMed ID: 19592662
[TBL] [Abstract][Full Text] [Related]
8. Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.
Schliehe C; Bitzer A; van den Broek M; Groettrup M
J Virol; 2012 Sep; 86(18):9782-93. PubMed ID: 22761378
[TBL] [Abstract][Full Text] [Related]
9. Cellular and humoral immunity against vaccinia virus infection of mice.
Xu R; Johnson AJ; Liggitt D; Bevan MJ
J Immunol; 2004 May; 172(10):6265-71. PubMed ID: 15128815
[TBL] [Abstract][Full Text] [Related]
10. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.
Yao Y; Li P; Singh P; Thiele AT; Wilkes DS; Renukaradhya GJ; Brutkiewicz RR; Travers JB; Luker GD; Hong SC; Blum JS; Chang CH
Cell Immunol; 2007 Apr; 246(2):92-102. PubMed ID: 17678637
[TBL] [Abstract][Full Text] [Related]
12. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
[TBL] [Abstract][Full Text] [Related]
14. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
15. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
Grandpre LE; Duke-Cohan JS; Ewald BA; Devoy C; Barouch DH; Letvin NL; Reinherz EL; Baden LR; Dolin R; Seaman MS
Vaccine; 2009 Mar; 27(10):1549-56. PubMed ID: 19168105
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.
Zuo J; Thomas WA; Haigh TA; Fitzsimmons L; Long HM; Hislop AD; Taylor GS; Rowe M
PLoS Pathog; 2011 Dec; 7(12):e1002455. PubMed ID: 22216005
[TBL] [Abstract][Full Text] [Related]
18. GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.
Judkowski V; Bunying A; Ge F; Appel JR; Law K; Sharma A; Raja-Gabaglia C; Norori P; Santos RG; Giulianotti MA; Slifka MK; Douek DC; Graham BS; Pinilla C
PLoS One; 2011; 6(9):e24091. PubMed ID: 21931646
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
Grosenbach DW; Jordan R; King DS; Berhanu A; Warren TK; Kirkwood-Watts DL; Tyavanagimatt S; Tan Y; Wilson RL; Jones KF; Hruby DE
Vaccine; 2008 Feb; 26(7):933-46. PubMed ID: 18226434
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.
Demkowicz WE; Maa JS; Esteban M
J Virol; 1992 Jan; 66(1):386-98. PubMed ID: 1727494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
